SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+6.45%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$412M
AUM Growth
+$412M
(+5.3%)
Cap. Flow
-$4.63M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
58.04%
Holding
34
New
6
Increased
9
Reduced
14
Closed
4
Top Buys
| 1 |
Pfizer
PFE
|
$31.5M |
| 2 |
CVS Health
CVS
|
$17.3M |
| 3 |
Medtronic
MDT
|
$8.83M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
$7.62M |
| 5 |
Illumina
ILMN
|
$5.65M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$19.5M |
| 2 |
Becton Dickinson
BDX
|
$18.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
$15.2M |
| 4 |
Cardinal Health
CAH
|
$10.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$9.43M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alkermes
ALKS
$4.78B
| $5.55M | 1.35% | +200,000 | New | +$5.55M |
|
27
Ultragenyx Pharmaceutical
RARE
$2.89B
| $4.9M | 1.19% | 102,490 -12,676 | -11% | -$606K |
|
28
Abbott
ABT
$231B
| $4.39M | 1.07% | +39,876 | New | +$4.39M |
|
29
Lantheus
LNTH
$3.73B
| $3.24M | 0.79% | 52,316 +1,354 | +3% | +$83.9K |
|
30
Vir Biotechnology
VIR
$686M
| $1.49M | 0.36% | 148,538 | – | – |
|
|
AMED
31
DELISTED
Amedisys
AMED
| – | – | -24,585 | Closed | -$2.3M |
|
|
32
Becton Dickinson
BDX
$55.3B
| – | – | -71,884 | Closed | -$18.6M |
|
33
Kenvue
KVUE
$39.7B
| – | – | -144,017 | Closed | -$2.89M |
|
|
CTLT
34
DELISTED
CATALENT, INC.
CTLT
| – | – | -207,129 | Closed | -$9.43M |
|